All articles tagged with #chemotaxis
Researchers at IBEC have developed the world's simplest artificial cell capable of chemotaxis, using lipid vesicles with enzymes and pores to navigate chemical gradients, shedding light on fundamental biological movement mechanisms.
Researchers have identified a potential strategy to reverse therapy resistance in prostate cancer by targeting myeloid chemotaxis. Myeloid cells play a crucial role in tumor progression and therapy resistance, and the study found that inhibiting the chemotaxis of these cells can enhance the effectiveness of existing therapies. The findings provide a promising avenue for developing targeted treatments for prostate cancer patients who have developed resistance to current therapies.